Ask a Patient® Health News: Drugs & Treatments

Ask a Patient® Health News: Drugs & Treatments

Home
Notes
Drug Safety Updates
Special Features
Archive
About
March 2025 Drug Safety Updates Part 1: Cardiac Risk Warning Removed for Testosterone Meds; News for Bactrim, Lybalvi, Nplate, Prolensa…
FDA Removes Cardiac Risk Warning on Testosterone Products
 • 
Katie Rowley
Drug and Device Approvals: Deep Brain Stimulation Therapy for PD; generic Xarelto; neffy nasal epinephrine spray; Odactra for dust mite…
Deep Brain Stimulation Therapy for Parkinson’s Disease

February 2025

February 2025 Part 3 Drug Safety News: Geodon; Paxlovid; Ozempic shortage ends; blood thinners and A-Fib; drug-induced high blood pressure…
Adcetris (brentuximab vedotin) for intravenous infusion
 • 
Katie Rowley
February 2025 Drug Safety Part 2: FDA REMS news; Abilify; Isoniazid; Ongentys for Parkinson's; Osphena for menopause
Dear Readers: We normally publish this newsletter every two weeks, but because of a two-week pause in FDA Safety Labeling Change posting activity…
February 2025 Drug Safety Updates Part 1: Enhertu, Omvoh, Ozempic expanded approvals and new warnings; MS drug's new boxed warning; glaucoma…
Copaxone (glatiramer acetate) subcutaneous injection
 • 
Katie Rowley

January 2025

New Formulations for Popular Meds; Nicotine and Health Risks; Generic Facility Warned; Anti-Aging Emerging Therapies and Hype; More
Nicotine Pouches Ok'd by FDA
January 2025 Part 1: Safety warning for RSV vaccines; Depo Provera contraceptive link to brain tumors; iron infusion therapy risk; Ozempic…
This week, included are two reports of safety issues (Depo Provera and Ozempic) that did not involve an FDA update but are noteworthy due to lawsuits…
 • 
Katie Rowley

December 2024

December 2024 Part 2: Eye drops recall; Veozah boxed warning; new topical eczema treatment; Rybelsus; Zepbound for sleep apnea; Ibrance…
Eye Drops Recall: Systane Lubricant
 • 
Katie Rowley
December 2024 Drug Safety Updates: Antidepressant and seizure drug recalls; Ocaliva and liver failure; new acne inversa med's label change…
Drug Recalls: Duloxetine and Clonazepam
 • 
Katie Rowley
Skin Reactions and NSAIDs
Safety Labeling Changes for Prescription NSAIDs Warn of Rare but Severe Skin Reactions
 • 
Katie Rowley
November 2024 Drug Safety Updates Part 4: Cancer Drugs: Ayvakit, Keytruda, Oxaliplatin, more
Ayvakit (avapritinib) tablets
 • 
Katie Rowley
Pulmonary Aspiration Warning for GLP-1 (Glucagon-like peptide-1) Diabetes and Weight Loss Meds
GLP-1 medications help patients lose weight by delaying the movement of food from the stomach into the small intestine, suppressing appetite.
© 2025 AskaPatient.com
Privacy ∙ Terms ∙ Collection notice
Start WritingGet the app
Substack is the home for great culture